Table 5 DLCO and FEV1% measured before and at 2 year post-radiotherapy against chemotherapy, TAM and smoking habits.
Adverse Event | group | Percentage of ≥G1 grade | p (§) | Percentage of ≥G2 grade | p (§) |
|---|---|---|---|---|---|
DLCO measured before radiotherapy respect to predicted value for each patient | |||||
| Â | Chemotherapy vs no chemotherapy | 78% vs. 22% | 0.006 | 38% vs 6% | 0.036 |
| Â | TAM vs no TAM | 43% vs. 44% | 0.755 | 14% vs 17% | 0.972 |
| Â | Smoking vs no smoking | 67% vs. 31% | 0.111 | 44% vs 19% | 0.299 |
DLCO measured at 2 year post-radiotherapy respect to predicted value for each patient | |||||
| Â | Chemotherapy vs no chemotherapy | 67% vs. 41% | 0.251 | 45% vs 19% | 0.258 |
| Â | TAM vs no TAM | 44% vs. 52% | 0.848 | 25% vs 29% | 0.993 |
| Â | Smoking vs no smoking | 54% vs. 46% | 0.930 | 31% vs 17% | 0.538 |
FEV1% measured before radiotherapy respect to predicted value for each patient | |||||
| Â | Chemotherapy vs no chemotherapy | 40% vs. 42% | 0.765 | 0% vs. 0% | - |
| Â | TAM vs no TAM | 36% vs. 43% | 0.996 | 0% vs. 0% | - |
| Â | Smoking vs no smoking | 40% vs. 41% | 0.882 | 0% vs. 0% | - |
FEV1% measured at 2y-post-radiotherapy respect to predicted value for each patient | |||||
| Â | Chemotherapy vs no chemotherapy | 44% vs. 50% | 0.890 | 0% vs. 4% | 0.673 |
| Â | TAM vs no TAM | 44% vs. 56% | 0.464 | 0% vs 6% | 0.853 |
| Â | Smoking vs no smoking | 62% vs. 5% | <0.001 | 0% vs 5% | 0.931 |